Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Review of Diabetic Studies : RDS|May 12, 2007
Visceral obesity and hemostatic profile in patients with type 2 diabetes: the effect of gender and metabolic compensationElzbieta Kozek, Barbara Katra, Maciej Malecki, et al.
Przeglad Lekarski|April 7, 2004
[Diabetes gravidarum--guidelines in the year 2003]Danuta Galicka-Latała, Elzbieta Kozek, Alicja Hebda-Szydło
Przeglad Lekarski|May 20, 2011
[Heart rate variability in type 1 diabetic patients with retinopathy. Part I. Frequency analysis]Danuta Galicka-Latała, Andrzej Surdacki, Ewa Konduracka, et al.
Przeglad Lekarski|April 29, 2003
[TNF-alpha PC-1 gene polymorphisms and pre-diabetes quantitative features in the Polish population]Krzysztof Wanic, Maciej Małecki, Tomasz Klupa, et al.
Przeglad Lekarski|April 3, 2004
[Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis]Elzbieta Kozek, Aleksandra Górska, Katarzyna Fross, et al.
Diabetes Technology & Therapeutics|March 10, 2010
Dipeptidyl peptidase-IV inhibitors are efficient adjunct therapy in HNF1A maturity-onset diabetes of the young patients--report of two casesBarbara Katra, Tomasz Klupa, Jan Skupien, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2010
The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancyTomasz Klupa, Elzbieta Kozek, Natalia Nowak, et al.
Diabetes Technology & Therapeutics|February 27, 2010
Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-upTomasz Klupa, Jan Skupien, Barbara Mirkiewicz-Sieradzka, et al.
Acta Diabetologica|February 22, 2012
Cystatin C is not a good candidate biomarker for HNF1A-MODYNatalia Nowak, Magdalena Szopa, Gaya Thanabalasingham, et al.
Pageof 1